Oropharyngeal colonization of HIV-infected outpatients in Taiwan by yeast pathogens

Journal of Clinical Microbiology

Volumn 48, Issue 7, 2010, Pages 2609-2612

  Yang, Yun Liang ^a   Hung, Chien Ching ^b   Wang, An Huei ^c   Tseng, Fan Chen ^c   Leaw, Shiang Ning ^c   Tseng, Yu Tzu ^b   Su, Chia Li ^c   Chen, Hui Ting ^a,c   Lauderdale, Tsai Ling ^c   Lo, Hsiu Jung ^c,d  

^a NATIONAL CHIAO TUNG UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^d CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; FLUCONAZOLE; FUNGUS ANTIBODY; PNEUMOCOCCUS VACCINE; ANTIFUNGAL AGENT;

ANTIBIOTIC THERAPY; ANTIFUNGAL RESISTANCE; ARTICLE; CANDIDA ALBICANS; CANDIDA DUBLINIENSIS; CANDIDA TROPICALIS; CANDIDEMIA; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; FUNGAL COLONIZATION; FUNGUS IDENTIFICATION; FUNGUS ISOLATION; HIGH RISK PATIENT; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MINIMUM INHIBITORY CONCENTRATION; MUCOCUTANEOUS CANDIDIASIS; OROPHARYNX CANDIDIASIS; OUTPATIENT; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; TAIWAN; VACCINATION; VIRUS LOAD; ADULT; CANDIDA; COMPLICATION; DRUG EFFECTS; FEMALE; HETEROZYGOTE; HIV INFECTIONS; ISOLATION AND PURIFICATION; MALE; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MIDDLE AGED; OROPHARYNX; RISK FACTOR; STATISTICAL MODEL;

CANDIDA;

ADULT; ANTIFUNGAL AGENTS; CANDIDA; CARRIER STATE; COHORT STUDIES; DRUG RESISTANCE, FUNGAL; FEMALE; FLUCONAZOLE; HIV INFECTIONS; HUMANS; LOGISTIC MODELS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; OROPHARYNX; OUTPATIENTS; RISK FACTORS; TAIWAN;

EID: 77954449741     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.00500-10     Document Type: Article

References (24)

1. Campisi, G., G. Pizzo, M. E. Milici, S. Mancuso, and V. Margiotta. 2002. Candidal carriage in the oral cavity of human immunodeficiency virus-infected subjects. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 93:281-286.
2. Chen, Y. M., and S. H. Kuo. 2007. HIV-1 in Taiwan. Lancet 369:623-625.
3. Cheng, M. F., Y. L. Yang, T. J. Yao, C. Y. Lin, J. S. Liu, R. B. Tang, K. W. Yu, Y. H. Fan, K. S. Hsieh, M. Ho, and H. J. Lo. 2005. Risk factors for fatal candidemia caused by Candida albicans and non-albicans Candida species. BMC Infect. Dis. 5:22.
4. Cheng, M. F., K. W. Yu, R. B. Tang, Y. H. Fan, Y. L. Yang, K. S. Hsieh, M. Ho, and H. J. Lo. 2004. Distribution and antifungal susceptibility of Candida species causing candidemia from 1996 to 1999. Diagn. Microbiol. Infect. Dis. 48:33-37.
5. Clinical and Laboratory Standards Institute. 2008. Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard, 3rd ed. CLSI document M27-A3. Clinical and Laboratory Standards Institute, Wayne, PA.
6. Delgado, A. C., R. de Jesus Pedro, F. H. Aoki, M. R. Resende, P. Trabasso, A. L. Colombo, M. S. de Oliveira, Y. Mikami, and M. L. Moretti. 2009. Clinical and microbiological assessment of patients with a long-term diagnosis of human immunodeficiency virus infection and Candida oral colonization. Clin. Microbiol. Infect. 15:364-371.
7. Dios, P. D., A. Ocampo, C. Miralles, J. Limeres, and I. Tomas. 2000. Changing prevalence of human immunodeficiency virus-associated oral lesions. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 90:403-404.
8. Fichtenbaum, C. J., S. Koletar, C. Yiannoutsos, F. Holland, J. Pottage, S. E. Cohn, A. Walawander, P. Frame, J. Feinberg, M. Saag, C. Van der Horst, and W. G. Powderly. 2000. Refractory mucosal candidiasis in advanced human immunodeficiency virus infection. Clin. Infect. Dis. 30:749-756.
9. Hsueh, P. R., M. L. Chen, C. C. Sun, W. H. Chen, H. J. Pan, L. S. Yang, S. C. Chang, S. W. Ho, C. Y. Lee, W. C. Hsieh, and K. T. Luh. 2002. Antimicrobial drug resistance in pathogens causing nosocomial infections at a university hospital in Taiwan, 1981-1999. Emerg. Infect. Dis. 8:63-68.
10. Hung, C. C., Y. L. Yang, T. L. Lauderdale, L. C. McDonald, C. F. Hsiao, H. H. Cheng, Y. A. Ho, and H. J. Lo. 2005. Colonization of human immunodeficiency virus-infected outpatients in Taiwan with Candida species. J. Clin. Microbiol. 43:1600-1603.
11. Leaw, S. N., H. C. Chang, R. Barton, J. P. Bouchara, and T. C. Chang. 2007. Identification of medically important Candida and non-Candida yeast species by an oligonucleotide array. J. Clin. Microbiol. 45:2220-2229.
12. Leaw, S. N., H. C. Chang, H. F. Sun, R. Barton, J. P. Bouchara, and T. C. Chang. 2006. Identification of medically important yeast species by sequence analysis of the internal transcribed spacer regions. J. Clin. Microbiol. 44:693-699.
13. Odds, F. C., and R. Bernaerts. 1994. CHROMagar Candida, a new differential isolation medium for presumptive identification of clinically important Candida species. J. Clin. Microbiol. 32:1923-1929.
14. Ohmit, S. E., J. D. Sobel, P. Schuman, A. Duerr, K. Mayer, A. Rompalo, and R. S. Klein. 2003. Longitudinal study of mucosal Candida species colonization and candidiasis among human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women. J. Infect. Dis. 188:118-127.
15. Patel, R., D. Portela, A. D. Badley, W. S. Harmsen, J. J. Larson-Keller, D. M. Ilstrup, M. R. Keating, R. H. Wiesner, R. A. Krom, and C. V. Paya. 1996. Risk factors of invasive Candida and non-Candida fungal infections after liver transplantation. Transplantation 62:926-934.
16. Perea, S., J. L. Lopez-Ribot, W. R. Kirkpatrick, R. K. McAtee, R. A. Santillan, M. Martinez, D. Calabrese, D. Sanglard, and T. F. Patterson. 2001. Prevalence of molecular mechanisms of resistance to azole antifungal agents in Candida albicans strains displaying high-level fluconazole resistance isolated from human immunodeficiency virus-infected patients. Antimicrob. Agents Chemother. 45:2676-2684.
17. Vanden Bossche, H., D. W. Warnock, B. Dupont, D. Kerridge, G. S. Sen, L. Improvisi, P. Marichal, F. C. Odds, F. Provost, and O. Ronin. 1994. Mechanisms and clinical impact of antifungal drug resistance. J. Med. Vet. Mycol. 32(Suppl. 1):189-202.
18. Vargas, K. G., and S. Joly. 2002. Carriage frequency, intensity of carriage, and strains of oral yeast species vary in the progression to oral candidiasis in human immunodeficiency virus-positive individuals. J. Clin. Microbiol. 40:341-350.
19. Yang, Y. L., M. F. Cheng, Y. W. Chang, T. G. Young, H. Chi, S. C. Lee, B. M. Cheung, F. C. Tseng, T. C. Chen, Y. H. Ho, Z. Y. Shi, C. H. Chan, J. Y. Lin, and H. J. Lo. 2008. Host factors do not influence the colonization or infection by fluconazole resistant Candida species in hospitalized patients. J. Negat. Results Biomed. 7:12.
20. Yang, Y. L., M. F. Cheng, C. W. Wang, A. H. Wang, W. T. Cheng, H. J. Lo, and YSARY Hospital. 2010. The distribution of species and susceptibility of amphotericin B and fluconazole of yeast pathogens isolated from sterile sites in Taiwan. Med. Mycol. 48:328-329.
21. Yang, Y. L., Y. A. Ho, H. H. Cheng, M. Ho, and H. J. Lo. 2004. Susceptibilities of Candida species to amphotericin B and fluconazole: the emergence of fluconazole resistance in Candida tropicalis. Infect. Control Hosp. Epidemiol. 25:60-64.
22. Yang, Y. L., S. Y. Li, H. H. Cheng, and H. J. Lo. 2005. Susceptibilities to amphotericin B and fluconazole of Candida species in TSARY 2002. Diagn. Microbiol. Infect. Dis. 51:179-183.
23. Yang, Y. L., H. J. Lo, C. C. Hung, and Y. Li. 2006. Effect of prolonged HAART on oral colonization with Candida and candidiasis. BMC Infect. Dis. 6:8.
24. Yang, Y. L., A. H. Wang, C. W. Wang, W. T. Cheng, S. Y. Li, H. J. Lo, and TSARY Hospitals. 2008. Susceptibilities to amphotericin B and fluconazole of Candida species in TSARY 2006. Diagn. Microbiol. Infect. Dis. 61:175-180.